The Kia Syros, Kia India’s second compact SUV, has made a solid entry into the Indian market. With 10,971 units dispatched in the first two months of 2025, the Syros is already making waves. Let’s dive into the details of its sales performance, market share, and how it stacks up against its rivals.
Kia Syros Sales Overview (Jan-Feb 2025)
The Kia Syros has been off to a promising start, contributing significantly to Kia India’s overall sales. Here’s a quick breakdown:
Month | Units Sold |
---|---|
January | 5,546 |
February | 5,425 |
Total | 10,971 |
The Syros accounts for 22% of Kia India’s total sales in 2025, tying with the popular Kia Carens MPV.
Kia Syros vs Kia’s Other Models
The Syros is already the third best-selling model for Kia India in 2025, trailing behind the Sonet and Seltos. Here’s a comparison of Kia’s wholesale numbers for February 2025:
Model | Feb 2025 Sales | Feb 2024 Sales | Change (%) |
---|---|---|---|
Sonet | 7,598 | 9,102 | -17% |
Seltos | 6,446 | 6,265 | +3% |
Syros | 5,425 | – | – |
Carens | 5,318 | 4,832 | +10% |
Carnival | 239 | – | – |
EV6 | 0 | 1 | -100% |
Total | 25,025 | 20,200 | +24% |
The Syros has outsold the Carens by a narrow margin of 131 units in the first two months of 2025.
Kia Syros vs Rivals: How Does It Fare?
While the Syros has shown strong performance, it still lags behind some of its competitors in the compact SUV segment. Here’s a look at how it compares to its rivals:
Model | Feb Sales | Jan Sales | Total | Market Share (%) |
---|---|---|---|---|
Maruti Fronx | 21,461 | 15,192 | 36,653 | 20.62% |
Tata Nexon | 15,349 | 15,397 | 30,746 | 17.30% |
Maruti Brezza | 15,392 | 14,747 | 30,139 | 16.96% |
Hyundai Venue | 10,125 | 11,106 | 21,231 | 11.95% |
Mahindra XUV 3XO | 7,861 | 8,454 | 16,315 | 9.18% |
Kia Sonet | 7,598 | 7,194 | 14,792 | 8.32% |
Kia Syros | 5,425 | 5,546 | 10,971 | 6.17% |
Toyota Taisor | 3,604 | 2,470 | 6,074 | 3.42% |
Skoda Kylaq | 3,636 | 1,242 | 4,878 | 2.74% |
Nissan Magnite | 2,328 | 2,404 | 4,732 | 2.66% |
Renault Kiger | 433 | 755 | 1,188 | 0.67% |
Total | – | – | 1,77,719 | 100% |
The Syros is currently positioned in the lower half of the compact SUV segment, outperforming models like the Skoda Kylaq, Nissan Magnite, and Renault Kiger but trailing behind the Maruti Fronx, Tata Nexon, and Hyundai Venue.
Kia India’s Overall Performance
Kia India’s wholesales in February 2025 stood at 25,025 units, marking a 24% year-on-year growth compared to February 2024. The cumulative sales for the 11-month period (April 2024-February 2025) reached 2,29,682 units, a 2.42% increase over the same period last year.
Key Takeaways
- The Kia Syros has contributed 22% to Kia India’s total sales in 2025.
- It is the third best-selling model for Kia, behind the Sonet and Seltos.
- The Syros has outsold the Carens by a small margin.
- Despite strong sales, it trails behind competitors like the Maruti Fronx and Tata Nexon.
FAQs
1. How many units of the Kia Syros were sold in January 2025?
- 5,546 units were sold in January 2025.
2. What is the market share of the Kia Syros in 2025?
- The Syros holds a 22% share of Kia India’s total sales.
3. Which Kia model is the best-seller in 2025?
- The Kia Sonet is the best-selling model with 14,792 units sold in Jan-Feb 2025.
4. How does the Syros compare to the Kia Carens?
- The Syros has outsold the Carens by 131 units in the first two months of 2025.
5. What is Kia India’s total wholesales in February 2025?
- Kia India dispatched 25,025 units in February 2025.
6. Which compact SUV outsold the Kia Syros in 2025?
- Models like the Maruti Fronx, Tata Nexon, and Hyundai Venue outsold the Syros.
7. What is the year-on-year growth in Kia India’s wholesales?
- Kia India’s wholesales grew by 24% in February 2025 compared to February 2024.
8. How does the Syros perform against the Skoda Kylaq?
- The Syros has outsold the Skoda Kylaq by a significant margin.
9. What is the total market share of the Kia Sonet?
- The Sonet holds an 8.32% market share in the compact SUV segment.
10. Which Kia model has the highest sales growth in 2025?
– The Kia Carens has shown a 10% growth in sales compared to 2024.